In this line, elevated plasma NKA concentration has been suggested as a biomarker of prognosis in patients suffering from midgut carcinoid tumors [150] and to predict survival in patients with small bowel neuroendocrine tumors [161,163]. Here, TAC1 is linked to small intestine neuroendocrine neoplasm.